Nektar Therapeutics Reports First Quarter 2026 Financial Results

Go back to Nektar Therapeutics Reports First Quarter 2026 Financial Results
Nektar Therapeutics (NASDAQ: NKTR) Delayed: 66.07 +5.09 (8.35%)
Previous Close $60.98    52 Week High $19.98 
Open $62.30    52 Week Low $10.52 
Day High $66.60    P/E N/A 
Day Low $62.30    EPS $-1.45 
Volume 620,294